Background—Implantable cardioverter-defibrillators (ICDs) improve survival in selected
patients with left ventricular systolic dysfunction in randomized trials. Competing death …

Background—Although implantable cardioverter-defibrillators (ICDs) reduce mortality in
primary prevention patients with left ventricular systolic dysfunction, recent studies have …

Background Eight randomized trials have evaluated whether the prophylactic use of an
implantable cardioverter–defibrillator (ICD) improves survival among patients who are at risk …

Background—The Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) showed
a significant 31 reduction in the risk of death with primary implantable cardioverter …

Aims Primary prevention implantable cardioverter defibrillators (ICDs) are established
therapy for reducing mortality in patients with left ventricular systolic dysfunction and …

Background—Underuse of implantable defibrillators has been previously noted in patients
at risk for sudden cardiac death, as well as for survivors of sudden cardiac death. We sought …

Background: The DANISH study (Danish Study to Assess the Efficacy of ICDs [Implantable
Cardioverter Defibrillators] in Patients With Non-Ischemic Systolic Heart Failure on Mortality) …

Sudden cardiac death (SCD) accounts for approximately one-third of all deaths among
patients with non-ischaemic cardiomyopathy (NICM). Implantable cardioverter-defibrillator …

Introduction: Little is known about the risk of appropriate implantable cardioverter‐
defibrillator (ICD) therapy outside the context of controlled clinical trials where routine …

Aims To reduce sudden cardiac death, implantable cardioverter-defibrillators (ICDs) are
indicated in patients with ischaemic and non-ischaemic dilated cardiomyopathy and a left …